Suppr超能文献

肝肿瘤浸润淋巴细胞:肝细胞癌和胆管细胞癌的比较。

Liver tumor infiltrating lymphocytes: comparison of hepatocellular and cholangiolar carcinoma.

机构信息

Department of Pathology, Medical Center, Clemenshospital Münster, Düesbergweg 128, D-48153 Münster, Germany.

出版信息

World J Gastroenterol. 2009 Oct 28;15(40):5053-7. doi: 10.3748/wjg.15.5053.

Abstract

AIM

To investigate the role of tumor infiltrating lymphocytes (TIL) in primary hepatocellular and cholangiolar carcinomas of the liver.

METHODS

Immunohistochemical analysis was performed including antibodies to CD3, CD4, CD8, CD20, CD56 and TIA-1 in formalin-fixed and paraffin-embedded tissue of 35 liver resection specimens of hepatocellular or cholangiocellular carcinomas. Semiquantitative evaluation was performed with emphasis on the area of the tumor itself and of the tumor/liver interface.

RESULTS

All hepatocellular carcinomas showed infiltration of lymphocytes predominantly around the tumor in the tumor/liver interface consisting mainly of CD3+ CD4+ T lymphocytes [164.3/10 high power fields (HPF)] and in the tumor itself of CD8+ cells (54.9/10 HPF). Cholangiocarcinomas contained a heterogeneous amount of TIL, composed mainly of CD3+ T cells with a predominance of CD8+ cells in the tumor tissue (52.6/10 HPF) and of CD4+ cells in the interface region (223.1/10 HPF). CD56+ cells of the innate immune system were scarce. There was no significant difference between hepatocellular or cholangiolar carcinoma. No correlation with the clinicopathological data was seen.

CONCLUSION

Liver TIL consists of intratumoral CD8+ T cells and peritumoral CD4+ T cells independent of histogenetic origin. Different functions of lymphocytes in these regions seem possible.

摘要

目的

研究肿瘤浸润淋巴细胞(TIL)在原发性肝细胞癌和肝内胆管细胞癌中的作用。

方法

对 35 例肝切除标本的福尔马林固定石蜡包埋组织进行了包括针对 CD3、CD4、CD8、CD20、CD56 和 TIA-1 的免疫组织化学分析。重点对肿瘤本身和肿瘤/肝界面的区域进行了半定量评估。

结果

所有肝细胞癌均显示淋巴细胞浸润,主要位于肿瘤/肝界面的肿瘤周围,主要由 CD3+CD4+T 淋巴细胞组成[164.3/10 高倍视野(HPF)],肿瘤本身则由 CD8+细胞组成(54.9/10 HPF)。胆管细胞癌含有数量不均的 TIL,主要由 CD3+T 细胞组成,肿瘤组织中 CD8+细胞占优势(52.6/10 HPF),界面区 CD4+细胞占优势(223.1/10 HPF)。固有免疫系统的 CD56+细胞很少。肝细胞癌或胆管细胞癌之间无显著差异。与临床病理资料无相关性。

结论

肝 TIL 由肿瘤内 CD8+T 细胞和肿瘤周围 CD4+T 细胞组成,与组织发生来源无关。这些区域的淋巴细胞可能具有不同的功能。

相似文献

1
Liver tumor infiltrating lymphocytes: comparison of hepatocellular and cholangiolar carcinoma.
World J Gastroenterol. 2009 Oct 28;15(40):5053-7. doi: 10.3748/wjg.15.5053.
3
Anti-tumor activity and mechanism of oligoclonal hepatocellular carcinoma tumor-infiltrating lymphocytes and .
Cancer Biol Ther. 2019;20(9):1187-1194. doi: 10.1080/15384047.2019.1599663. Epub 2019 Apr 24.
6
Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors.
Int J Cancer. 1990 Nov 15;46(5):878-83. doi: 10.1002/ijc.2910460521.
7
Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma.
Eur J Surg Oncol. 2008 Feb;34(2):173-9. doi: 10.1016/j.ejso.2007.08.008. Epub 2007 Oct 10.
8
Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes.
J Gastroenterol Hepatol. 2007 May;22(5):690-6. doi: 10.1111/j.1440-1746.2006.04551.x.
10
Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Cancer. 1994 Aug 15;74(4):1275-82. doi: 10.1002/1097-0142(19940815)74:4<1275::aid-cncr2820740416>3.0.co;2-q.

引用本文的文献

2
Causal role of immune cells in primary liver cancer: a mendelian randomization study.
BMC Cancer. 2025 May 23;25(1):928. doi: 10.1186/s12885-025-14327-1.
8
Tumor microenvironment and immunology of cholangiocarcinoma.
Hepatoma Res. 2022;8. doi: 10.20517/2394-5079.2021.140. Epub 2022 Mar 10.
9
Causal relationship between immune cell phenotypes and risk of biliary tract cancer: evidence from Mendelian randomization analysis.
Front Immunol. 2024 Jul 10;15:1430551. doi: 10.3389/fimmu.2024.1430551. eCollection 2024.

本文引用的文献

1
Use of tumour-responsive T cells as cancer treatment.
Lancet. 2009 Feb 21;373(9664):673-83. doi: 10.1016/S0140-6736(09)60404-9.
2
Preferential in situ CD4+CD56+ T cell activation and expansion within human glioblastoma.
J Immunol. 2008 Jun 1;180(11):7673-80. doi: 10.4049/jimmunol.180.11.7673.
3
Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
Cancer Res. 2008 Apr 15;68(8):2993-3000. doi: 10.1158/0008-5472.CAN-07-5008.
4
Multiple roles for CD4+ T cells in anti-tumor immune responses.
Immunol Rev. 2008 Apr;222:129-44. doi: 10.1111/j.1600-065X.2008.00616.x.
6
The immunological milieu of the liver.
Semin Liver Dis. 2007 May;27(2):129-39. doi: 10.1055/s-2007-979466.
7
Tregs and rethinking cancer immunotherapy.
J Clin Invest. 2007 May;117(5):1167-74. doi: 10.1172/JCI31202.
8
Quantifying tumour-infiltrating lymphocyte subsets: a practical immuno-histochemical method.
J Immunol Methods. 2007 Apr 10;321(1-2):32-40. doi: 10.1016/j.jim.2007.01.012. Epub 2007 Feb 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验